ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Living Biological Drugs Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-1W12142
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Living Biological Drugs Market Research Report 2022
BUY CHAPTERS

Global Living Biological Drugs Market Research Report 2025

Code: QYRE-Auto-1W12142
Report
March 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Osel
Takeda
AOBiome
Synlogic
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
MATRISYS BIOSCIENCE
Ardeypharman
Infant Bacterial Therapeutics
Finch Therapeutics
Luina Bio
List Labs

Living Biological Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Living Biological Drugs Market

Living Biological Drugs Market

The global market for Living Biological Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Living Biological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Living Biological Drugs.
The Living Biological Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Living Biological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Living Biological Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Living Biological Drugs Market Report

Report Metric Details
Report Name Living Biological Drugs Market
CAGR 5%
Segment by Type
  • Single Strain
  • Multi Strain
  • Co-Culture
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome, Synlogic, Finch Therapeutics, Capsugel, Jeneil Biotech, UAS Labs, Biose, Cerbios-Pharma, Inpac Probiotics, NIZO, Winclove Probiotics, BJP Laboratories, Luina Bio, List Labs, MatriSys Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Living Biological Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Living Biological Drugs Market report?

Ans: The main players in the Living Biological Drugs Market are Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome, Synlogic, Finch Therapeutics, Capsugel, Jeneil Biotech, UAS Labs, Biose, Cerbios-Pharma, Inpac Probiotics, NIZO, Winclove Probiotics, BJP Laboratories, Luina Bio, List Labs, MatriSys Bioscience

What are the Application segmentation covered in the Living Biological Drugs Market report?

Ans: The Applications covered in the Living Biological Drugs Market report are Digestive System, Urinary System, Skin System

What are the Type segmentation covered in the Living Biological Drugs Market report?

Ans: The Types covered in the Living Biological Drugs Market report are Single Strain, Multi Strain, Co-Culture

Recommended Reports

Biological & Biosimilar Drugs

Pharmaceutical Services

Immune & Specialty Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Living Biological Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Strain
1.2.3 Multi Strain
1.2.4 Co-Culture
1.3 Market by Application
1.3.1 Global Living Biological Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Digestive System
1.3.3 Urinary System
1.3.4 Skin System
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Living Biological Drugs Market Perspective (2020-2031)
2.2 Global Living Biological Drugs Growth Trends by Region
2.2.1 Global Living Biological Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Living Biological Drugs Historic Market Size by Region (2020-2025)
2.2.3 Living Biological Drugs Forecasted Market Size by Region (2026-2031)
2.3 Living Biological Drugs Market Dynamics
2.3.1 Living Biological Drugs Industry Trends
2.3.2 Living Biological Drugs Market Drivers
2.3.3 Living Biological Drugs Market Challenges
2.3.4 Living Biological Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Living Biological Drugs Players by Revenue
3.1.1 Global Top Living Biological Drugs Players by Revenue (2020-2025)
3.1.2 Global Living Biological Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Living Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Living Biological Drugs Revenue
3.4 Global Living Biological Drugs Market Concentration Ratio
3.4.1 Global Living Biological Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Living Biological Drugs Revenue in 2024
3.5 Global Key Players of Living Biological Drugs Head office and Area Served
3.6 Global Key Players of Living Biological Drugs, Product and Application
3.7 Global Key Players of Living Biological Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Living Biological Drugs Breakdown Data by Type
4.1 Global Living Biological Drugs Historic Market Size by Type (2020-2025)
4.2 Global Living Biological Drugs Forecasted Market Size by Type (2026-2031)
5 Living Biological Drugs Breakdown Data by Application
5.1 Global Living Biological Drugs Historic Market Size by Application (2020-2025)
5.2 Global Living Biological Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Living Biological Drugs Market Size (2020-2031)
6.2 North America Living Biological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Living Biological Drugs Market Size by Country (2020-2025)
6.4 North America Living Biological Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Living Biological Drugs Market Size (2020-2031)
7.2 Europe Living Biological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Living Biological Drugs Market Size by Country (2020-2025)
7.4 Europe Living Biological Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Living Biological Drugs Market Size (2020-2031)
8.2 Asia-Pacific Living Biological Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Living Biological Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Living Biological Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Living Biological Drugs Market Size (2020-2031)
9.2 Latin America Living Biological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Living Biological Drugs Market Size by Country (2020-2025)
9.4 Latin America Living Biological Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Living Biological Drugs Market Size (2020-2031)
10.2 Middle East & Africa Living Biological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Living Biological Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Living Biological Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ardeypharman
11.1.1 Ardeypharman Company Details
11.1.2 Ardeypharman Business Overview
11.1.3 Ardeypharman Living Biological Drugs Introduction
11.1.4 Ardeypharman Revenue in Living Biological Drugs Business (2020-2025)
11.1.5 Ardeypharman Recent Development
11.2 Miyarisan Pharmaceutical
11.2.1 Miyarisan Pharmaceutical Company Details
11.2.2 Miyarisan Pharmaceutical Business Overview
11.2.3 Miyarisan Pharmaceutical Living Biological Drugs Introduction
11.2.4 Miyarisan Pharmaceutical Revenue in Living Biological Drugs Business (2020-2025)
11.2.5 Miyarisan Pharmaceutical Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Details
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Living Biological Drugs Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Living Biological Drugs Business (2020-2025)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Seres Therapeutics
11.4.1 Seres Therapeutics Company Details
11.4.2 Seres Therapeutics Business Overview
11.4.3 Seres Therapeutics Living Biological Drugs Introduction
11.4.4 Seres Therapeutics Revenue in Living Biological Drugs Business (2020-2025)
11.4.5 Seres Therapeutics Recent Development
11.5 Infant Bacterial Therapeutics
11.5.1 Infant Bacterial Therapeutics Company Details
11.5.2 Infant Bacterial Therapeutics Business Overview
11.5.3 Infant Bacterial Therapeutics Living Biological Drugs Introduction
11.5.4 Infant Bacterial Therapeutics Revenue in Living Biological Drugs Business (2020-2025)
11.5.5 Infant Bacterial Therapeutics Recent Development
11.6 Osel
11.6.1 Osel Company Details
11.6.2 Osel Business Overview
11.6.3 Osel Living Biological Drugs Introduction
11.6.4 Osel Revenue in Living Biological Drugs Business (2020-2025)
11.6.5 Osel Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Living Biological Drugs Introduction
11.7.4 Takeda Revenue in Living Biological Drugs Business (2020-2025)
11.7.5 Takeda Recent Development
11.8 AOBiome
11.8.1 AOBiome Company Details
11.8.2 AOBiome Business Overview
11.8.3 AOBiome Living Biological Drugs Introduction
11.8.4 AOBiome Revenue in Living Biological Drugs Business (2020-2025)
11.8.5 AOBiome Recent Development
11.9 Synlogic
11.9.1 Synlogic Company Details
11.9.2 Synlogic Business Overview
11.9.3 Synlogic Living Biological Drugs Introduction
11.9.4 Synlogic Revenue in Living Biological Drugs Business (2020-2025)
11.9.5 Synlogic Recent Development
11.10 Finch Therapeutics
11.10.1 Finch Therapeutics Company Details
11.10.2 Finch Therapeutics Business Overview
11.10.3 Finch Therapeutics Living Biological Drugs Introduction
11.10.4 Finch Therapeutics Revenue in Living Biological Drugs Business (2020-2025)
11.10.5 Finch Therapeutics Recent Development
11.11 Capsugel
11.11.1 Capsugel Company Details
11.11.2 Capsugel Business Overview
11.11.3 Capsugel Living Biological Drugs Introduction
11.11.4 Capsugel Revenue in Living Biological Drugs Business (2020-2025)
11.11.5 Capsugel Recent Development
11.12 Jeneil Biotech
11.12.1 Jeneil Biotech Company Details
11.12.2 Jeneil Biotech Business Overview
11.12.3 Jeneil Biotech Living Biological Drugs Introduction
11.12.4 Jeneil Biotech Revenue in Living Biological Drugs Business (2020-2025)
11.12.5 Jeneil Biotech Recent Development
11.13 UAS Labs
11.13.1 UAS Labs Company Details
11.13.2 UAS Labs Business Overview
11.13.3 UAS Labs Living Biological Drugs Introduction
11.13.4 UAS Labs Revenue in Living Biological Drugs Business (2020-2025)
11.13.5 UAS Labs Recent Development
11.14 Biose
11.14.1 Biose Company Details
11.14.2 Biose Business Overview
11.14.3 Biose Living Biological Drugs Introduction
11.14.4 Biose Revenue in Living Biological Drugs Business (2020-2025)
11.14.5 Biose Recent Development
11.15 Cerbios-Pharma
11.15.1 Cerbios-Pharma Company Details
11.15.2 Cerbios-Pharma Business Overview
11.15.3 Cerbios-Pharma Living Biological Drugs Introduction
11.15.4 Cerbios-Pharma Revenue in Living Biological Drugs Business (2020-2025)
11.15.5 Cerbios-Pharma Recent Development
11.16 Inpac Probiotics
11.16.1 Inpac Probiotics Company Details
11.16.2 Inpac Probiotics Business Overview
11.16.3 Inpac Probiotics Living Biological Drugs Introduction
11.16.4 Inpac Probiotics Revenue in Living Biological Drugs Business (2020-2025)
11.16.5 Inpac Probiotics Recent Development
11.17 NIZO
11.17.1 NIZO Company Details
11.17.2 NIZO Business Overview
11.17.3 NIZO Living Biological Drugs Introduction
11.17.4 NIZO Revenue in Living Biological Drugs Business (2020-2025)
11.17.5 NIZO Recent Development
11.18 Winclove Probiotics
11.18.1 Winclove Probiotics Company Details
11.18.2 Winclove Probiotics Business Overview
11.18.3 Winclove Probiotics Living Biological Drugs Introduction
11.18.4 Winclove Probiotics Revenue in Living Biological Drugs Business (2020-2025)
11.18.5 Winclove Probiotics Recent Development
11.19 BJP Laboratories
11.19.1 BJP Laboratories Company Details
11.19.2 BJP Laboratories Business Overview
11.19.3 BJP Laboratories Living Biological Drugs Introduction
11.19.4 BJP Laboratories Revenue in Living Biological Drugs Business (2020-2025)
11.19.5 BJP Laboratories Recent Development
11.20 Luina Bio
11.20.1 Luina Bio Company Details
11.20.2 Luina Bio Business Overview
11.20.3 Luina Bio Living Biological Drugs Introduction
11.20.4 Luina Bio Revenue in Living Biological Drugs Business (2020-2025)
11.20.5 Luina Bio Recent Development
11.21 List Labs
11.21.1 List Labs Company Details
11.21.2 List Labs Business Overview
11.21.3 List Labs Living Biological Drugs Introduction
11.21.4 List Labs Revenue in Living Biological Drugs Business (2020-2025)
11.21.5 List Labs Recent Development
11.22 MatriSys Bioscience
11.22.1 MatriSys Bioscience Company Details
11.22.2 MatriSys Bioscience Business Overview
11.22.3 MatriSys Bioscience Living Biological Drugs Introduction
11.22.4 MatriSys Bioscience Revenue in Living Biological Drugs Business (2020-2025)
11.22.5 MatriSys Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Osel
Takeda
AOBiome
Synlogic
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
MATRISYS BIOSCIENCE
Ardeypharman
Infant Bacterial Therapeutics
Finch Therapeutics
Luina Bio
List Labs
List of Tables
 Table 1. Global Living Biological Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Single Strain
 Table 3. Key Players of Multi Strain
 Table 4. Key Players of Co-Culture
 Table 5. Global Living Biological Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Living Biological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Living Biological Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Living Biological Drugs Market Share by Region (2020-2025)
 Table 9. Global Living Biological Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Living Biological Drugs Market Share by Region (2026-2031)
 Table 11. Living Biological Drugs Market Trends
 Table 12. Living Biological Drugs Market Drivers
 Table 13. Living Biological Drugs Market Challenges
 Table 14. Living Biological Drugs Market Restraints
 Table 15. Global Living Biological Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Living Biological Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Living Biological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Living Biological Drugs as of 2024)
 Table 18. Ranking of Global Top Living Biological Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Living Biological Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Living Biological Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Living Biological Drugs, Product and Application
 Table 22. Global Key Players of Living Biological Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Living Biological Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Living Biological Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Living Biological Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Living Biological Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Living Biological Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Living Biological Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Living Biological Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Living Biological Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Living Biological Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Living Biological Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Living Biological Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Living Biological Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Living Biological Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Living Biological Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Living Biological Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Living Biological Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Living Biological Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Living Biological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Living Biological Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Living Biological Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Ardeypharman Company Details
 Table 48. Ardeypharman Business Overview
 Table 49. Ardeypharman Living Biological Drugs Product
 Table 50. Ardeypharman Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 51. Ardeypharman Recent Development
 Table 52. Miyarisan Pharmaceutical Company Details
 Table 53. Miyarisan Pharmaceutical Business Overview
 Table 54. Miyarisan Pharmaceutical Living Biological Drugs Product
 Table 55. Miyarisan Pharmaceutical Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 56. Miyarisan Pharmaceutical Recent Development
 Table 57. Ferring Pharmaceuticals Company Details
 Table 58. Ferring Pharmaceuticals Business Overview
 Table 59. Ferring Pharmaceuticals Living Biological Drugs Product
 Table 60. Ferring Pharmaceuticals Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 61. Ferring Pharmaceuticals Recent Development
 Table 62. Seres Therapeutics Company Details
 Table 63. Seres Therapeutics Business Overview
 Table 64. Seres Therapeutics Living Biological Drugs Product
 Table 65. Seres Therapeutics Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 66. Seres Therapeutics Recent Development
 Table 67. Infant Bacterial Therapeutics Company Details
 Table 68. Infant Bacterial Therapeutics Business Overview
 Table 69. Infant Bacterial Therapeutics Living Biological Drugs Product
 Table 70. Infant Bacterial Therapeutics Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 71. Infant Bacterial Therapeutics Recent Development
 Table 72. Osel Company Details
 Table 73. Osel Business Overview
 Table 74. Osel Living Biological Drugs Product
 Table 75. Osel Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 76. Osel Recent Development
 Table 77. Takeda Company Details
 Table 78. Takeda Business Overview
 Table 79. Takeda Living Biological Drugs Product
 Table 80. Takeda Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 81. Takeda Recent Development
 Table 82. AOBiome Company Details
 Table 83. AOBiome Business Overview
 Table 84. AOBiome Living Biological Drugs Product
 Table 85. AOBiome Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 86. AOBiome Recent Development
 Table 87. Synlogic Company Details
 Table 88. Synlogic Business Overview
 Table 89. Synlogic Living Biological Drugs Product
 Table 90. Synlogic Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 91. Synlogic Recent Development
 Table 92. Finch Therapeutics Company Details
 Table 93. Finch Therapeutics Business Overview
 Table 94. Finch Therapeutics Living Biological Drugs Product
 Table 95. Finch Therapeutics Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 96. Finch Therapeutics Recent Development
 Table 97. Capsugel Company Details
 Table 98. Capsugel Business Overview
 Table 99. Capsugel Living Biological Drugs Product
 Table 100. Capsugel Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 101. Capsugel Recent Development
 Table 102. Jeneil Biotech Company Details
 Table 103. Jeneil Biotech Business Overview
 Table 104. Jeneil Biotech Living Biological Drugs Product
 Table 105. Jeneil Biotech Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 106. Jeneil Biotech Recent Development
 Table 107. UAS Labs Company Details
 Table 108. UAS Labs Business Overview
 Table 109. UAS Labs Living Biological Drugs Product
 Table 110. UAS Labs Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 111. UAS Labs Recent Development
 Table 112. Biose Company Details
 Table 113. Biose Business Overview
 Table 114. Biose Living Biological Drugs Product
 Table 115. Biose Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 116. Biose Recent Development
 Table 117. Cerbios-Pharma Company Details
 Table 118. Cerbios-Pharma Business Overview
 Table 119. Cerbios-Pharma Living Biological Drugs Product
 Table 120. Cerbios-Pharma Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 121. Cerbios-Pharma Recent Development
 Table 122. Inpac Probiotics Company Details
 Table 123. Inpac Probiotics Business Overview
 Table 124. Inpac Probiotics Living Biological Drugs Product
 Table 125. Inpac Probiotics Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 126. Inpac Probiotics Recent Development
 Table 127. NIZO Company Details
 Table 128. NIZO Business Overview
 Table 129. NIZO Living Biological Drugs Product
 Table 130. NIZO Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 131. NIZO Recent Development
 Table 132. Winclove Probiotics Company Details
 Table 133. Winclove Probiotics Business Overview
 Table 134. Winclove Probiotics Living Biological Drugs Product
 Table 135. Winclove Probiotics Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 136. Winclove Probiotics Recent Development
 Table 137. BJP Laboratories Company Details
 Table 138. BJP Laboratories Business Overview
 Table 139. BJP Laboratories Living Biological Drugs Product
 Table 140. BJP Laboratories Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 141. BJP Laboratories Recent Development
 Table 142. Luina Bio Company Details
 Table 143. Luina Bio Business Overview
 Table 144. Luina Bio Living Biological Drugs Product
 Table 145. Luina Bio Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 146. Luina Bio Recent Development
 Table 147. List Labs Company Details
 Table 148. List Labs Business Overview
 Table 149. List Labs Living Biological Drugs Product
 Table 150. List Labs Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 151. List Labs Recent Development
 Table 152. MatriSys Bioscience Company Details
 Table 153. MatriSys Bioscience Business Overview
 Table 154. MatriSys Bioscience Living Biological Drugs Product
 Table 155. MatriSys Bioscience Revenue in Living Biological Drugs Business (2020-2025) & (US$ Million)
 Table 156. MatriSys Bioscience Recent Development
 Table 157. Research Programs/Design for This Report
 Table 158. Key Data Information from Secondary Sources
 Table 159. Key Data Information from Primary Sources
 Table 160. Authors List of This Report


List of Figures
 Figure 1. Living Biological Drugs Picture
 Figure 2. Global Living Biological Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Living Biological Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Single Strain Features
 Figure 5. Multi Strain Features
 Figure 6. Co-Culture Features
 Figure 7. Global Living Biological Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Living Biological Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Digestive System Case Studies
 Figure 10. Urinary System Case Studies
 Figure 11. Skin System Case Studies
 Figure 12. Living Biological Drugs Report Years Considered
 Figure 13. Global Living Biological Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Living Biological Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Living Biological Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Living Biological Drugs Market Share by Players in 2024
 Figure 17. Global Top Living Biological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Living Biological Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Living Biological Drugs Revenue in 2024
 Figure 19. North America Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Living Biological Drugs Market Share by Country (2020-2031)
 Figure 21. United States Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Living Biological Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Living Biological Drugs Market Share by Region (2020-2031)
 Figure 33. China Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Living Biological Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Living Biological Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Living Biological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Ardeypharman Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 49. Miyarisan Pharmaceutical Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 50. Ferring Pharmaceuticals Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 51. Seres Therapeutics Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 52. Infant Bacterial Therapeutics Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 53. Osel Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 54. Takeda Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 55. AOBiome Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 56. Synlogic Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 57. Finch Therapeutics Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 58. Capsugel Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 59. Jeneil Biotech Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 60. UAS Labs Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 61. Biose Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 62. Cerbios-Pharma Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 63. Inpac Probiotics Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 64. NIZO Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 65. Winclove Probiotics Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 66. BJP Laboratories Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 67. Luina Bio Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 68. List Labs Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 69. MatriSys Bioscience Revenue Growth Rate in Living Biological Drugs Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Live long Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Global Pharmerging Market Research Report 2025
Global Anti Infectives Market Research Report 2025
Global CGT Drugs Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Global Combination Therapy Drug Market Research Report 2025
Global Aquaculture Bacterial Diagnosis Market Research Report 2025
Global BioPharma Service Market Research Report 2024
Global Immune Drugs Market Insights Forecast to 2030
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemical Dosing Units Market Research Report 2025
Global Ant Killer Market Research Report 2024
Global Bio Similars Subsequent Entry Biologic Market Research Report 2024
Global Anti infectious Disease Drugs Market Research Report 2025
Global Pill Organizer with Timer Reminder Market Research Report 2025

RELATED REPORTS

Clinical Chemistry and Immunoassay Reagents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-19L14408
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Global Prescription Dermatology Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30F12967
Thu Sep 04 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Asset Managements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28K11948
Thu Sep 04 00:00:00 UTC 2025

Add to Cart

Global Cell Therapy Technologies Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T13444
Thu Sep 04 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions